CS268645B1 - Derivatives of thioallophanic acid - Google Patents

Derivatives of thioallophanic acid Download PDF

Info

Publication number
CS268645B1
CS268645B1 CS887193A CS719388A CS268645B1 CS 268645 B1 CS268645 B1 CS 268645B1 CS 887193 A CS887193 A CS 887193A CS 719388 A CS719388 A CS 719388A CS 268645 B1 CS268645 B1 CS 268645B1
Authority
CS
Czechoslovakia
Prior art keywords
derivatives
mol
compounds
acid
thioallophanic
Prior art date
Application number
CS887193A
Other languages
Czech (cs)
Other versions
CS719388A1 (en
Inventor
Jaroslav Ing Sluka
Viktor Ing Csc Zikan
Jaroslav Mvdr Csc Danek
Original Assignee
Sluka Jaroslav
Zikan Viktor
Danek Jaroslav
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sluka Jaroslav, Zikan Viktor, Danek Jaroslav filed Critical Sluka Jaroslav
Priority to CS887193A priority Critical patent/CS268645B1/en
Publication of CS719388A1 publication Critical patent/CS719388A1/en
Publication of CS268645B1 publication Critical patent/CS268645B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

- (Dwg.No.0/0)(0/0)

Description

Vynález se týká methylesterů v poloze 4 disubstituovaných thioa1lofanových kyselin obecného vzorceThe present invention relates to methyl esters at the 4-position of disubstituted thioalofanoic acids of the general formula

X N-CS-NHC00CH3 (I), kde X je atom síry nebo iminová skupina/ substituovaná methylem.X N-CS-NHCOCH 3 (I) wherein X is a sulfur atom or an imine group / substituted with methyl.

Tyto nové dosud nepopsané látky vykazují použitelnou anthelmintickou účinnost, zejména proti modelovému helmintu Hymenolepis nana.These novel substances, which have not yet been described, exhibit useful anthelmintic activity, in particular against the model helminth of Hymenolepis nana.

Sloučeniny obecného vzorce I podle vynálezu lze připravit reakcí thiomorfo1 inu nebo N-methylpiperazinu s methoxykarbony 1isothickyanátem v prostředí acetonu při teplotě 20 až 40 °C.The compounds of the formula I according to the invention can be prepared by reacting thiomorpholine or N-methylpiperazine with methoxycarbonyl isothicyanate in acetone at 20 to 40 ° C.

Methoxykarbony1isothiokyanát byl získán reakcí thiokyanatanu draselného s methylesterem ch loromravenčí kyseliny v prostředí vroucího acetonu.Methoxycarbonyl isothiocyanate was obtained by reacting potassium thiocyanate with chloroformic acid methyl ester in boiling acetone.

Hodnocení anthelmintické účinnosti proti modelovému helmintu Hymenolepis nana:Evaluation of anthelmintic activity against model helminth Hymenolepis nana:

Testy byly provedeny na myších samcích kmene H s hmotností 10 až 13 g ve skupinách po 6 kusech. Ově ze tří kontrolních skupin byly invadované, neléčené, třetí invadovaná, léčena standardním přípravkem - piperazinovou solí niclosamidu - vůči němuž byla účinnost látek porovnávána. Invase byla prováděna sondou perorálně vždy 500 zralými vajíčky tasennice Hymenolepis nana v objemu 0,25 ml/myš. Sloučeniny obecného vzorce I byly aplikovány 13. a 14. den po invasi perorálně sondou v dávce 150 mg.kg1 živé hmotnosti, jako homogenát v Dorfmannově činidle. Myši byly usmrceny 3. den po aplikaci a po zjištění celkového počtu tasemnic se skolexy při úplné, helmintologické pitvě tenkého střeva myší byla výpočtem metodou nepřímé aktivity dle Stewarda stanovena anthelmintická účinnost. Standard byl aplikován rovněž 13. a 14. den po invasi v dávce 150 mg.kg1 Živé hmotnosti.The tests were performed on male H strain mice weighing 10-13 g in groups of 6 each. Of the three control groups, the controls were invaded, untreated, the third invaded, treated with a standard formulation - niclosamide piperazine salt - against which the efficacy of the compounds was compared. Invasion was performed by probing orally with 500 mature Hymenolepis nana tapeworm eggs in a volume of 0.25 ml / mouse. Compounds of formula I were administered on the 13th and 14th day after the invasion by oral gavage at a dose of 150 mg.kg 1 liveweight as homogenates Dorfmannově agent. Mice were sacrificed on day 3 after administration and, after total colonic tapeworm counts at complete, helminthological dissection of the small intestine of mice, anthelmintic efficacy was determined by Steward's indirect activity calculation. The standard was also applied to the 13th and 14th day after the invasion in a dose of 150 mg.kg 1 bodyweight.

Antihelmintická účinnost sloučenin obecného vzorce nana vyjádřená v procentech metodou nepříméThe anthelmintic activity of the compounds of formula nana, expressed as a percentage by the indirect method

Hymenolepis dující: иHymenolepis: no

I proti modelovému helmintu aktivity dle stewarda je náslelátky dle látky dle př íк ladu př íkladu provedení 1 provedení 2Even against the model helminth activity according to steward is the follower according to the substance according to example example 1

75.2 %75.2%

71.2 % v ní71.2% in it

Způsob uspokojivých výtěžcích. Bližší • Uvedené příklady vynález pouze ilustrují, přípravy látek podle a poskytuje žádané produkty vynálezu je jednoduchý podrobnosti vyplývají z následujících příkladů provedenikoliv omezuj í·Method of satisfactory yields. DETAILED DESCRIPTION OF THE INVENTION The following examples are merely illustrative of the preparation of the compounds of the present invention and provide the desired products of the invention.

Příklad iExample i

4-(Me thoxykarbonylamino th ioka rbony1)th iomor fo1 i n4- (Methoxycarbonylamino thiocarbonyl) thiomorpholine

К roztoku 5,83 g (0,06 mol) thiokyanatanu draselného ve 125 ml acetonu přidáno 5,67 g (4/62 «1’ 0/06 mol) methylesteru chloromravenČ1 kyseliny a směs vařena 30 min· pod zpětným chladičem· po chlazení na teplotu 20 °C byl odsát vyloučený chlorid draselný а к filtrátu bylo za míchání přikapáno 5/16 g (5,02 ml* 0,05 mol) thiomorfolinu. Kapalná reakční směs míchána 5 h, potom oddestilována ve vakuu aceton, kapalný zbytek zředěn 60 ml methanolu a ponechán 24 h v chladničce při teplotě 5 °C. Vyloučená látka odsáta a překrystalizována z methanolu· Získáno 6,05 g (55,0 %) látky tající při 124 až 125 °C o složení C7H 12 N2°2S2*To a solution of potassium thiocyanate (5.83 g, 0.06 mol) in acetone (125 ml), 5.67 g (4/62 1 0.06 mol) of methyl chloroformate were added and the mixture was refluxed for 30 min. · After cooling. The precipitated potassium chloride was aspirated to 20 ° C and 5/16 g (5.02 mL * 0.05 mol) of thiomorpholine was added dropwise to the filtrate with stirring. The liquid reaction mixture was stirred for 5 h, then distilled under vacuum in acetone, the liquid residue diluted with 60 mL of methanol and left in a refrigerator at 5 ° C for 24 h. The precipitate was filtered off with suction and recrystallised from methanol · Get 6.05 g (55.0%) of material melting at 124-125 ° C of the composition C 7 H 12 N 2 S 2 ° 2 *

Příklad 2Example 2

4—(Methoxykarbonylaminoth iokarbonyl)-l-methylp iperaz in4- (Methoxycarbonylaminothiocarbonyl) -1-methylpiperazine

Způsobem popsaným v příkladu 1 byla z 5,83 g (0,06 mol) thiokyanataůu draselnéhoThe method described in Example 1 was potassium thiocyanate (5.83 g, 0.06 mol)

5/67 g (0/006 mol) methylesteru chloromravenčí kyseliny a 5/01 g (0,05 wol) 1-methylpiperazinu připravena surová látka/ která byla překrlstalizována z methanolu· Získáno5/67 g (0/006 mol) of methyl chloroformate and 5/01 g (0.05 wol) of 1-methylpiperazine prepared as a crude material, which was recrystallized from methanol · Obtained

5,27 g (48,6 %) látky tající při 158 až 159 °C o aložení C8H15N302S.5.27 g (48.6%) of a substance melting at 158-159 ° C, depositing C 8 H 15 N 3 0 2 S.

Claims (1)

PŘEDMĚT VYNÁLEZUSUBJECT OF THE INVENTION Deriváty thioa1lofanové kyseliny obecného vzorce IThioalofanoic acid derivatives of the general formula I X N-CS-NHCOOCH3 kde X je atom síry nebo iminová skupino, substituovaná methylem.X is N-CS-NHCOOCH 3 wherein X is a sulfur atom or an imine group substituted with methyl.
CS887193A 1988-11-01 1988-11-01 Derivatives of thioallophanic acid CS268645B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CS887193A CS268645B1 (en) 1988-11-01 1988-11-01 Derivatives of thioallophanic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS887193A CS268645B1 (en) 1988-11-01 1988-11-01 Derivatives of thioallophanic acid

Publications (2)

Publication Number Publication Date
CS719388A1 CS719388A1 (en) 1989-08-14
CS268645B1 true CS268645B1 (en) 1990-03-14

Family

ID=5420620

Family Applications (1)

Application Number Title Priority Date Filing Date
CS887193A CS268645B1 (en) 1988-11-01 1988-11-01 Derivatives of thioallophanic acid

Country Status (1)

Country Link
CS (1) CS268645B1 (en)

Also Published As

Publication number Publication date
CS719388A1 (en) 1989-08-14

Similar Documents

Publication Publication Date Title
DE60225316T2 (en) CYANO ALKYLAMINO DERIVATIVES AS PROTEASE INHIBITORS
DE69828276T2 (en) New cyclic diamine compounds and remedies containing them
US4512998A (en) Anthelmintic benzimidazole carbamates
DE19912638A1 (en) Naphthylcarboxamide substituted sulfonamides
DE19920790A1 (en) Bis-sulfonamides with anti-HCMV activity
DE4304650A1 (en) Condensed 5-membered heterocycles, processes for their preparation and pharmaceutical compositions containing them
EP0612738A1 (en) Diphenylpiperazine derivative and drug for circulatory organ containing the same
EP0228959B1 (en) Aminostyryl compound, leukotriene antagonistic composition containing the same as effective ingredients and method of antagonizing srs by employing the same
US6969711B2 (en) Cyclic diamine compounds and medicine containing the same
EP0041047A2 (en) Dioxide compounds, process for their preparation and their use
EP0019440B1 (en) Benzimidazolone derivatives, process for their preparation and pharmaceutical compositions containing them
AU2006277794A1 (en) Dihydroxyanthraquinones and their use
HU200451B (en) Process for production of derivatives of 1,2-ditiol-3-tion and medical compositions containing them as active substance
US5344842A (en) Thiosemicarbazone derivatives
US3504026A (en) Benzenesulfonyl-ureas
DE3135250A1 (en) TRICYCLIC THIAZOLYLOXAMATES, METHOD FOR THE PRODUCTION THEREOF AND THERAPEUTIC AGENTS CONTAINING THEM
CS268645B1 (en) Derivatives of thioallophanic acid
EP0211157B1 (en) Isoxazole derivatives, process for their preparation and phamaceutical compositions containing them
GB2148296A (en) 1,2-dithiolan derivatives, process for their production pharmaceutical compositions containing them and their use
US3894033A (en) 5-Aryltetrazoles
EP0192191B1 (en) Homocysteine thiolactone derivatives, process for the preparation thereof and pharmaceutical compositions therefrom
US3853876A (en) Ortho-mercaptoaroylamides and salts thereof abstract of the disclosure
US3475450A (en) Arylsulfonylureas and arylsulfonylthioureas
US5246927A (en) Benzazole derivatives, processes for their preparation containing such compounds and the use thereof
SU1553012A3 (en) Method of producing derivatives of 9-(2-propoxymethyl)guanine